title: Plasma insulin-like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality.
abstract: BACKGROUND
  Insulin-like growth factor I (IGF-I) has beneficial metabolic effects. Because plasma IGF-I levels have been reported to be enhanced by dehydroepiandrosterone (DHEA) administration, it has been suggested that the IGF-I may be implicated in some of the reported associations between low DHEA sulfate (DHEAS) levels and impaired health measures in elderly subjects. The nutritional status, which also regulates plasma IGF-I levels, is also an important determinant of health outcome.
  
  
  OBJECTIVE
  We sought to investigate the associations between plasma IGF-I levels and plasma DHEAS levels, nutritional status, health, and mortality in the elderly.
  
  
  METHODS
  In 256 community-dwelling subjects aged 65-101 years, enrolled in the Paquid study, a health questionnaire was used to acertain their functional disabilities, any history of medical disorders, self-perceived health, depressive symptoms, and their cognitive function. Biological measurements included levels of plasma IGF-I, albumin, transthyretin, and DHEAS. Mortality data were available for 6 years following blood sampling.
  
  
  RESULTS
  In this elderly population with no impairment in nutritional status, the plasma IGF-I levels decreased significantly with age (p = 0.02). The plasma IGF-I levels correlated positively with those of transthyretin (p = 0.0001). IGF-I also correlated with DHEAS (p = 0.04), but the correlation did not remain significant after adjustment for age. As opposed to SDHEA, the plasma IGF-I levels did not correlate with the results from the health questionnaire. The baseline IGF-I values in the highest tertile were associated with a higher risk of short-term mortality than those in the lowest tertile (RR = 8.4 at 2 years, p = 0.007).
  
  
  CONCLUSIONS
  Our results suggest that IGF-I is not connected with the association between low plasma DHEAS levels and the impaired results from the health questionnaire. The relationship between plasma IGF-I highest levels and mortality should be further explored.
authors.affiliation: Unité de Médecine Nutritionnelle Gériatrique, Hôpital Charles-Foix AP-HP, Ivry-sur-Seine, France.
authors.forename: A
authors.initials: A
authors.lastname: Raynaud-Simon
authors.forename: S
authors.initials: S
authors.lastname: Lafont
authors.forename: C
authors.initials: C
authors.lastname: Berr
authors.forename: J F
authors.initials: JF
authors.lastname: Dartigues
authors.forename: E E
authors.initials: EE
authors.lastname: Baulieu
authors.forename: Y
authors.initials: Y
authors.lastname: Le Bouc
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D005260:Female; D006304:Health Status; D006306:Health Surveys; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008297:Male; D009026:Mortality; D009752:Nutritional Status; D012709:Serum Albumin / Q000032:analysis
chemical_list: D012709:Serum Albumin; D019314:Dehydroepiandrosterone Sulfate; D007334:Insulin-Like Growth Factor I